Myeloma Canada is committed to providing you with the most reliable, relevant and up-to-date information on the coronavirus COVID-19 and myeloma as possible. That’s why we created the COVID-19 & Myeloma InfoBulletin.

This week subjects included:

• Protecting cancer patients from COVID-19: World-first clinical trial tests a novel immune-boosting strategy
   
• What is the best way to treat COVID-19? Remdesivir and plasma are promising, but other drugs are needed.
   
• Are kids key vectors in the spread of COVID-19 or not? U of C scientists want to know
   
• Canadian company to collaborate on potential coronavirus vaccine with GSK
   
• Selinexor COVID-19 Global Trial Launching
   
• COVID-19 & Myeloma Webinars

Click here to read more.